🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
iX Biopharma Ltd. (SGX:42C)
Singapore flag Singapore · Delayed Price · Currency is SGD
0.4550
0.00 (0.00%)
At close: Nov 18, 2026

iX Biopharma Balance Sheet

Millions SGD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
11.3614.740.871.776.5213.49
Short-Term Investments
-0.190.070.070.020.09
Cash & Short-Term Investments
11.3614.930.941.846.5313.59
Cash Growth
97.05%1496.47%-49.27%-71.79%-51.91%118.65%
Accounts Receivable
2.30.951.031.291.250.5
Other Receivables
-1.030.911.631.81.48
Receivables
2.31.971.942.923.051.98
Inventory
1.241.190.921.380.960.91
Prepaid Expenses
-0.520.410.440.440.37
Other Current Assets
0.56-----
Total Current Assets
15.4518.614.216.5910.9816.84
Property, Plant & Equipment
7.087.136.727.618.227.72
Long-Term Investments
---0.013.872.26
Goodwill
--0.270.290.290.31
Other Intangible Assets
00-0-0.04
Long-Term Deferred Tax Assets
----1.381.28
Other Long-Term Assets
0.130.130.090.130.190.07
Total Assets
22.6725.8811.2814.6224.9328.52

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
4.321.161.31.260.40.22
Accrued Expenses
0.193.022.992.872.812.31
Current Portion of Long-Term Debt
2.975.224.082.492.753.29
Current Portion of Leases
0.280.310.270.390.440.24
Current Income Taxes Payable
-0.190.180.170.731.76
Other Current Liabilities
0.150.110.140.210.050.04
Total Current Liabilities
7.910.018.987.387.187.86
Long-Term Debt
0.110.121.472.180.570.88
Long-Term Leases
0.090.150.080.140.58-
Other Long-Term Liabilities
0.150.20.390.580.760.04
Total Liabilities
8.2610.4810.9210.289.088.77

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
127.18125.67100.8397.4597.2394.18
Retained Earnings
-118.23-114.9-107.12-96.98-86.18-76.57
Comprehensive Income & Other
5.474.626.653.874.82.13
Shareholders' Equity
14.4115.40.374.3415.8519.74
Total Liabilities & Equity
22.6725.8811.2814.6224.9328.52

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
3.445.85.95.24.344.41
Net Cash (Debt)
7.929.13-4.97-3.362.29.18
Net Cash Growth
-----76.08%363.97%
Net Cash Per Share
0.010.01-0.01-0.000.000.01
Filing Date Shares Outstanding
1,0751,093887.96883.34766.3764.9
Total Common Shares Outstanding
1,0751,068887.96768.32766.3751.19
Working Capital
7.558.61-4.77-0.83.88.99
Book Value Per Share
0.010.010.000.010.020.03
Tangible Book Value
14.4115.390.14.0515.5619.4
Tangible Book Value Per Share
0.010.010.000.010.020.03
Land
-2.542.382.572.562.73
Buildings
-1.721.611.741.741.85
Machinery
-7.256.76.996.716.6
Leasehold Improvements
-0.750.710.760.740.64